Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5309328, 14 pages
http://dx.doi.org/10.1155/2016/5309328
Research Article

Aryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis

1Biomolecular Sciences Ph.D. Program, Boise State University, Boise, ID 83725, USA
2Department of Biological Sciences, Boise State University, Boise, ID 83725, USA
3Biomolecular Research Center, Boise State University, Boise, ID 83725, USA
4Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725, USA

Received 7 May 2016; Revised 26 July 2016; Accepted 4 August 2016

Academic Editor: Kim Bridle

Copyright © 2016 Cheri L. Lamb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. V. Beischlag, J. L. Morales, B. D. Hollingshead, and G. H. Perdew, “The aryl hydrocarbon receptor complex and the control of gene expression,” Critical Reviews in Eukaryotic Gene Expression, vol. 18, no. 3, pp. 207–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Hankinson, “The aryl hydrocarbon receptor complex,” Annual Review of Pharmacology and Toxicology, vol. 35, pp. 307–340, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-Z. Gu, J. B. Hogenesch, and C. A. Bradfield, “The PAS superfamily: sensors of environmental and developmental signals,” Annual Review of Pharmacology and Toxicology, vol. 40, pp. 519–561, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Fernandez-Salguero, D. M. Hllbert, S. Rudikoff, J. M. Ward, and F. J. Gonzalez, “Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity,” Toxicology and Applied Pharmacology, vol. 140, no. 1, pp. 173–179, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Jackson, A. D. Joshi, and C. J. Elferink, “Ah receptor pathway intricacies; signaling through diverse protein partners and DNA-motifs,” Toxicology Research, vol. 4, no. 5, pp. 1143–1158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Mitchell and C. J. Elferink, “Timing is everything: consequences of transient and sustained AhR activity,” Biochemical Pharmacology, vol. 77, no. 6, pp. 947–956, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Barouki, X. Coumoul, and P. M. Fernandez-Salguero, “The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein,” FEBS Letters, vol. 581, no. 19, pp. 3608–3615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Karsdal, T. Manon-Jensen, F. Genovese et al., “Novel insights into the function and dynamics of extracellular matrix in liver fibrosis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 308, no. 10, pp. G807–G830, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-H. Kim, J. Turnbull, and S. Guimond, “Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor,” Journal of Endocrinology, vol. 209, no. 2, pp. 139–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. A. Andreasen, L. K. Mathew, and R. L. Tanguay, “Regenerative growth is impacted by TCDD: gene expression analysis reveals extracellular matrix modulation,” Toxicological Sciences, vol. 92, no. 1, pp. 254–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. C. Aragon, P. G. Kopf, M. J. Campen, J. K. Huwe, and M. K. Walker, “In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology,” Toxicological Sciences, vol. 101, no. 2, pp. 321–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nottebrock, K. Riecke, M. Kruse, M. Shakibaei, and R. Stahlmann, “Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on the extracellular matrix of the thymus in juvenile marmosets (Callithrix jacchus),” Toxicology, vol. 226, no. 2-3, pp. 197–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Riecke, D. Grimm, M. Shakibaei et al., “Low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin increase transforming growth factor β and cause myocardial fibrosis in marmosets (Callithrix jacchus),” Archives of Toxicology, vol. 76, no. 5-6, pp. 360–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Pierre, A. Chevallier, F. Teixeira-Clerc et al., “Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin,” Toxicological Sciences, vol. 137, no. 1, pp. 114–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Haque, J. Francis, and I. Sehgal, “Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines,” Cancer Letters, vol. 225, no. 1, pp. 159–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Murphy, C. M. Villano, R. Dorn, and L. A. White, “Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 25284–25293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Villano, K. A. Murphy, A. Akintobi, and L. A. White, “2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells,” Toxicology and Applied Pharmacology, vol. 210, no. 3, pp. 212–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Andreasen, L. K. Mathew, C. V. Löhr, R. Hasson, and R. L. Tanguay, “Aryl hydrocarbon receptor activation impairs extracellular matrix remodeling during zebra fish fin regeneration,” Toxicological Sciences, vol. 95, no. 1, pp. 215–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Friedman, “Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury,” Journal of Biological Chemistry, vol. 275, no. 4, pp. 2247–2250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Duarte, J. Baber, T. Fujii, and A. J. Coito, “Matrix metalloproteinases in liver injury, repair and fibrosis,” Matrix Biology, vol. 44–46, pp. 147–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Friedman, “Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver,” Physiological Reviews, vol. 88, no. 1, pp. 125–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. F. W.-Y. Wong, W.-Y. Chan, and S. S.-T. Lee, “Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression,” Toxicology and Applied Pharmacology, vol. 153, no. 1, pp. 109–118, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Mederacke, C. C. Hsu, J. S. Troeger et al., “Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology,” Nature Communications, vol. 4, article 2823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Lamb, G. N. Cholico, X. Pu, G. D. Hagler, K. A. Cornell, and K. A. Mitchell, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
  25. C. Frantz, K. M. Stewart, and V. M. Weaver, “The extracellular matrix at a glance,” Journal of Cell Science, vol. 123, no. 24, pp. 4195–4200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Widmer, J. M. Gebauer, E. Brunstein et al., “Molecular basis for the action of the collagen-specific chaperone Hsp47/SERPINH1 and its structure-specific client recognition,” Proceedings of the National Academy of Sciences, vol. 109, no. 33, pp. 13243–13247, 2012. View at Publisher · View at Google Scholar
  27. K. G. Danielson, H. Baribault, D. F. Holmes, H. Graham, K. E. Kadler, and R. V. Iozzo, “Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility,” Journal of Cell Biology, vol. 136, no. 3, pp. 729–743, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. I. T. Weber, R. W. Harrison, and R. V. Iozzo, “Model structure of decorin and implications for collagen fibrillogenesis,” The Journal of Biological Chemistry, vol. 271, no. 50, pp. 31767–31770, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Zhang, Y. Ezura, I. Chervoneva et al., “Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development,” Journal of Cellular Biochemistry, vol. 98, no. 6, pp. 1436–1449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. B. Liu, N. Ikenaga, Z. Peng et al., “Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice,” The FASEB Journal, vol. 30, no. 4, pp. 1599–1609, 2016. View at Publisher · View at Google Scholar
  31. M. P. Caley, V. L. Martins, and E. A. O'Toole, “Metalloproteinases and wound healing,” Advances in Wound Care, vol. 4, no. 4, pp. 225–234, 2015. View at Publisher · View at Google Scholar
  32. H. Nagase, R. Visse, and G. Murphy, “Structure and function of matrix metalloproteinases and TIMPs,” Cardiovascular Research, vol. 69, no. 3, pp. 562–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Fallowfield, M. Mizuno, T. J. Kendall et al., “Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis,” The Journal of Immunology, vol. 178, no. 8, pp. 5288–5295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Ramachandran, A. Pellicoro, M. A. Vernon et al., “Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. E3186–E3195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. E. Morrill, A. N. Tulepbergenov, C. J. Stender, R. Lamichhane, R. J. Brown, and T. J. Lujan, “A validated software application to measure fiber organization in soft tissue,” Biomechanics and Modeling in Mechanobiology, 2016. View at Publisher · View at Google Scholar
  36. P. S. Aranda, D. M. Lajoie, and C. L. Jorcyk, “Bleach gel: a simple agarose gel for analyzing RNA quality,” Electrophoresis, vol. 33, no. 2, pp. 366–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. L. C. U. Junqueira, G. Bignolas, and R. R. Brentani, “Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections,” The Histochemical Journal, vol. 11, no. 4, pp. 447–455, 1979. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Hadler-Olsen, P. Kanapathippillai, E. Berg, G. Svineng, J.-O. Winberg, and L. Uhlin-Hansen, “Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity,” Journal of Histochemistry and Cytochemistry, vol. 58, no. 1, pp. 29–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Kumar, T. Smith, K. Rahman, N. E. Thorn, and F. A. Anania, “Adiponectin agonist ADP355 attenuates CCL4-induced liver fibrosis in mice,” PLoS ONE, vol. 9, no. 10, Article ID e110405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. E. G. Canty and K. E. Kadler, “Procollagen trafficking, processing and fibrillogenesis,” Journal of Cell Science, vol. 118, no. 7, pp. 1341–1353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. L. C. U. Junqueira, G. Bignolas, and R. R. Brentani, “Picrosirius staining plus polarization microscopy: a specific method for collagen detection in tissue sections,” The Histochemical Journal, vol. 11, no. 4, pp. 447–455, 1979. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Rich and P. Whittaker, “Collagen and picrosirius red staining: a polarized light assessment of fibrillar hue and spatial distribution,” Journal of Morphological Science, vol. 22, no. 2, pp. 97–104, 2005. View at Google Scholar
  44. D. Rodríguez, C. J. Morrison, and C. M. Overall, “Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1803, no. 1, pp. 39–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. P. Iredale, A. Thompson, and N. C. Henderson, “Extracellular matrix degradation in liver fibrosis: biochemistry and regulation,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 7, pp. 876–883, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. G. M. Huang and C. J. Elferink, “A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression,” Molecular Pharmacology, vol. 81, no. 3, pp. 338–347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. D.-S. Son and K. K. Rozman, “2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines,” Archives of Toxicology, vol. 76, no. 7, pp. 404–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. S. R. Wilson, A. D. Joshi, and C. J. Elferink, “The tumor suppressor kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner,” Journal of Pharmacology and Experimental Therapeutics, vol. 345, no. 3, pp. 419–429, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. J. S. Duffield, S. J. Forbes, C. M. Constandinou et al., “Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair,” The Journal of Clinical Investigation, vol. 115, no. 1, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Knittel, M. Mehde, D. Kobold, B. Saile, C. Dinter, and G. Ramadori, “Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1,” Journal of Hepatology, vol. 30, no. 1, pp. 48–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Pellicoro, P. Ramachandran, and J. P. Iredale, “Reversibility of liver fibrosis,” Fibrogenesis & Tissue Repair, vol. 5, no. 1, p. 1, 2012. View at Google Scholar
  52. M. Rojkind, M. A. Giambrone, and L. Biempica, “Collagen types in normal and cirrhotic liver,” Gastroenterology, vol. 76, no. 4, pp. 710–719, 1979. View at Google Scholar · View at Scopus
  53. E. A. Thackaberry, Z. Jiang, C. D. Johnson, K. S. Ramos, and M. K. Walker, “Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes,” Toxicological Sciences, vol. 88, no. 1, pp. 231–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. R. G. Wells, “Cellular sources of extracellular matrix in hepatic fibrosis,” Clinics in Liver Disease, vol. 12, no. 4, pp. 759–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Ala-Kokko, T. Pihlajaniemi, J. C. Myers, K. I. Kivirikko, and E. R. Savolainen, “Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat,” Biochemical Journal, vol. 244, no. 1, pp. 75–79, 1987. View at Publisher · View at Google Scholar · View at Scopus
  56. K. M. Mak, P. Sehgal, and C. K. Harris, “Type VI collagen: its biology and value as a biomarker of hepatic fibrosis,” Austin Biomarkers & Diagnosis, vol. 1, no. 2, article 9, 2014. View at Google Scholar
  57. W. A. Harvey, K. Jurgensen, X. Pu et al., “Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation,” Toxicology, vol. 344–346, pp. 26–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. J. A. Walisser, E. Glover, K. Pande, A. L. Liss, and C. A. Bradfield, “Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 49, pp. 17858–17863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. M. Carvajal-Gonzalez, A. C. Roman, M. I. Cerezo-Guisado, E. M. Rico-Leo, G. Martin-Partido, and P. M. Fernandez-Salguero, “Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFβ,” Journal of Cell Science, vol. 122, no. 11, pp. 1823–1833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Fernandez-Salguero, T. Pineau, D. M. Hilbert et al., “Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor,” Science, vol. 268, no. 5211, pp. 722–726, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Zaher, P. M. Fernandez-Salguero, J. Letterio et al., “The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis,” Molecular Pharmacology, vol. 54, no. 2, pp. 313–321, 1998. View at Google Scholar · View at Scopus
  62. M. Choudhary, D. Kazmin, P. Hu, R. S. Thomas, D. P. McDonnell, and G. Malek, “Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways,” Journal of Pathology, vol. 235, no. 1, pp. 101–112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Kawasaki, R. Ushioda, S. Ito, K. Ikeda, Y. Masago, and K. Nagata, “Deletion of the collagen-specific molecular chaperone Hsp47 causes endoplasmic reticulum stress-mediated apoptosis of hepatic stellate cells,” The Journal of Biological Chemistry, vol. 290, no. 6, pp. 3639–3646, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Taguchi and M. S. Razzaque, “The collagen-specific molecular chaperone HSP47: is there a role in fibrosis?” Trends in Molecular Medicine, vol. 13, no. 2, pp. 45–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Sunamoto, K. Kuze, H. Tsuji et al., “Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis,” Laboratory Investigation, vol. 78, no. 8, pp. 967–972, 1998. View at Google Scholar · View at Scopus
  66. H. Pan and J. Halper, “Regulation of heat shock protein 47 and type I procollagen expression in avian tendon cells,” Cell and Tissue Research, vol. 311, no. 3, pp. 373–382, 2003. View at Google Scholar · View at Scopus
  67. K. Baghy, R. V. Iozzo, and I. Kovalszky, “Decorin-TGFβ axis in hepatic fibrosis and cirrhosis,” Journal of Histochemistry and Cytochemistry, vol. 60, no. 4, pp. 262–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Guo, M. Sartor, S. Karyala et al., “Expression of genes in the TGF-β signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice,” Toxicology and Applied Pharmacology, vol. 194, no. 1, pp. 79–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. X. Chang, Y. Fan, S. Karyala et al., “Ligand-independent regulation of transforming growth factor β1 expression and cell cycle progression by the aryl hydrocarbon receptor,” Molecular and Cellular Biology, vol. 27, no. 17, pp. 6127–6139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. H. M. Kagan and W. Li, “Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell,” Journal of Cellular Biochemistry, vol. 88, no. 4, pp. 660–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. J. M. Hillegass, K. A. Murphy, C. M. Villano, and L. A. White, “The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease,” Biological Chemistry, vol. 387, no. 9, pp. 1159–1173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. K. A. Murphy, C. M. Villano, R. Dorn, and L. A. White, “Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25284–25293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. C. F. A. Vogel, E. Sciullo, and F. Matsumura, “Activation of inflammatory mediators and potential role of Ah-receptor ligands in foam cell formation,” Cardiovascular Toxicology, vol. 4, no. 4, pp. 363–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. T. M. Igarashi, K. L. Bruner-Tran, G. R. Yeaman et al., “Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin,” Fertility and Sterility, vol. 84, no. 1, pp. 67–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. A.-M. Préaux, A. Mallat, J. T. Van Nhieu, M.-P. D'Ortho, R. M. Hembry, and P. Mavier, “Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions,” Hepatology, vol. 30, no. 4, pp. 944–950, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Arpino, M. Brock, and S. E. Gill, “The role of TIMPs in regulation of extracellular matrix proteolysis,” Matrix Biology, vol. 44–46, pp. 247–254, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Wang, F. Lafdil, L. Wang, S. Yin, D. Feng, and B. Gao, “Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: Involvement of hepatocyte STAT3 in TIMP-1 production,” Cell and Bioscience, vol. 1, no. 1, article 140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. A. H. Baker, D. R. Edwards, and G. Murphy, “Metalloproteinase inhibitors: biological actions and therapeutic opportunities,” Journal of Cell Science, vol. 115, no. 19, pp. 3719–3727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Mizutani, M. Yoshino, T. Satake et al., “Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta,” Endocrine Journal, vol. 51, no. 6, pp. 569–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. P. R. Hanlon, M. A. Cimafranca, X. Liu, Y. C. Cho, and C. R. Jefcoate, “Microarray analysis of early adipogenesis in C3H10T1/2 cells: cooperative inhibitory effects of growth factors and 2,3,7,8-tetrachlorodibenzo-p-dioxin,” Toxicology and Applied Pharmacology, vol. 207, no. 1, pp. 39–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. J. M. Martinez, C. A. Afshari, P. R. Bushel, A. Masuda, T. Takahashi, and N. J. Walker, “Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells,” Toxicological Sciences, vol. 69, no. 2, pp. 409–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. K. W. Gaido and S. C. Maness, “Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line,” Toxicology and Applied Pharmacology, vol. 133, no. 1, pp. 34–42, 1995. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Shimba, M. Hayashi, H. Sone, J. Yonemoto, and M. Tezuka, “2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces binding of a 50—kDa protein on the 3′ untranslated region of urokinase-type plasminogen activator mRNA,” Biochemical and Biophysical Research Communications, vol. 272, no. 2, pp. 441–448, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. J. R. Boehm, S. M. Kutz, E. H. Sage, L. Staiano-Coico, and P. J. Higgins, “Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1,” Journal of Cellular Physiology, vol. 181, no. 1, pp. 96–106, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Staršíchová, E. Hrubá, E. Slabáková et al., “TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells,” Cellular Signalling, vol. 24, no. 8, pp. 1665–1676, 2012. View at Publisher · View at Google Scholar